High expression of nucleoporin 133 mRNA in bone marrow CD138+ cells is a poor prognostic factor in multiple myeloma

Recent advances in plasma cell biology and molecularly-targeted therapy enable us to employ various types of drugs including immunomodulatory drugs, proteasome inhibitors, and immunotherapy. However, the optimal therapeutic strategies to introduce these drugs for heterogeneous patients with multiple...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Ibata, Soushi, Kobune, Masayoshi, Kikuchi, Shohei, Yoshida, Masahiro, Miura, Shogo, Horiguchi, Hiroto, Murase, Kazuyuki, Iyama, Satoshi, Takada, Kohichi, Miyanishi, Koji, Kato, Junji
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2018
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5982762/
https://ncbi.nlm.nih.gov/pubmed/29861858
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25350
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados